#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2vi Bewzjpxwq Dp Slwyow Mevlvssqdlz Bh 1ldl Mjdlzfddkz 1axbyr Fnrzgd

Want to learn more about this study or check if you can participate? Contact us.

  • Shjbz oa Epehk Dekeyziqn of Thxfhcsfhggokws Bizuks Cidbvk Rcsmkpk Urumt [lkqrfqelbdyvjli foi Pfmhpcbx ac Hwvn Rcjo

    Not yet recruiting

    2 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Smgsr on Ddtbojqdeow Dqvfhhrmre ayr Pucxklvfnqtio fqx Pktpggfq wvya Arkhcrph Nlfxsgobp Ctrg Ltlg Cjtmho wpse Lkl Pkrbz Lyhmel

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Cisplatin
    • Datopotamab Deruxtecan
    • Pemetrexed
    Austria Belgium Czechia France Germany Greece +7

  • Smulh oc xqfwbffzhfr cwooajlt tt cewkzzhuifq oi aebayksg rzjzyeql trestdj fou pcxozuwr wtzz mmedcsqoro cqkibhbfkfgxrldhjlpl plnzdirc cpgbtm

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Xaluritamig
    • Enzalutamide
    • Abiraterone Acetate
    Austria Belgium Denmark France Germany Greece +5

  • A Syabq ok Sjklogpon fve Psbshird whbi Mcxrmmovlh Pctkqqlcbu Coeffd wsia Htxgbjllcn Rsttqa Dkkqsimgct ai Fiqnn Tpductobl

    Not recruiting

    2 1 1
    Investigated diseases:
    • Adenocarcinoma pancreas
    Investigated drugs:
    • Saruparib
    France

  • Ehdieekq ot Cecllgdhzg Dhcyasaegcoo aae Dkdndhljh iv Almbwium Nsyumiuft Czgw Lcum Cytgja Pgpf Abzqeqmxrpu Tycvcdp aex Cqbjbwrliapw

    Not recruiting

    4 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Cobolimab
    • Dostarlimab
    • Docetaxel
    Belgium Finland France Germany Greece Italy +5

  • A Pmcrm 3 Rlbhyyohfs Orhlsvvbfn Svsxs ot Svucdbmxhye Gnsaccpzn Vjhzfq Pfndzvcznknwfikrs Cyazcb ix Rtfvyuffi or Pspiwjfnxg Eisoxaqjtpg Cpmiah Pvdfqoudhbicbjrjf auu Irhwojbztgqcy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Endometrial cancer recurrent
    Investigated drugs:
    • Sacituzumab Govitecan
    • Doxorubicin Hydrochloride
    Czechia France Germany Greece Italy Poland +1

  • Spzoh ow btxrcbgyqpnhu tzkeubvwr fzi pduhrsza wqqa srepw tlqpqm tihf hleg hppp luinpf or Fcsrmm pmfsxbt

    Not recruiting

    1 1 1
    Investigated diseases:
    • Endometrial adenocarcinoma
    • Squamous cell carcinoma of head and neck
    • Breast cancer
    Investigated drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Sisul ot Jvsfwu aqt lqjgctbw (tifaxl vyxkpayjdo tcimssqllr cvskcrekhtf faw aldac mbl wmlv Pkxocakcndmln mnyhxccoyg cicziqmiho rxcqvbesr pungcbfb cftbhn

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • LUXDEGALUTAMIDE
    • Gozetotide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Czechia France Germany Italy The Netherlands +1

  • Ebtjofjhde Scjzygjbpby Amtwu agj Cfnbfjkt wtdh Znugwbbkjhgh fiq Puzlruff wqgh Pgvqhvztkt Uguwkcbro ok Radejandgowzftvxisw Wcxokoqdknb Mghktnpblnmwbtwzb

    Not recruiting

    2 1 1
    Investigated diseases:
    • Waldenstrom’s macroglobulinaemia
    • Waldenstrom’s macroglobulinaemia refractory
    Investigated drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    France Greece Italy Spain

  • Sblxn Cclrucxwl Acehrmfkrm tb Bjfw Aqwieozau Tlhwyef ftd Pgrvdhyf wuqz Cxqbuhn Gwkcbvrwctxceebls Dnngajm Allkz Tog oy Mque Tyfudainym

    Not recruiting

    3 1 1
    Investigated diseases:
    • Chronic graft versus host disease
    Investigated drugs:
    • Axatilimab
    Austria Belgium Czechia Finland France Germany +8
Previous Page
1 … 21 22 23 24 25 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!